Skip to main content
Equibles
SNNC logo

SNNC · Sibannac, Inc. · Metrics

Track SNNC — free

Use SNNC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SNNC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.01 +0.00 (+20.00%) At close · Sep 17
Rebalance outlook locked
Market Cap
$80,625
Shares
17.53M

SNNC metrics

39 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.01
Market cap
$80,625

Price action

20 metrics
Price change (1W)
+10.0%
Price change (30D)
-15.4%
Price change (3M)
-38.9%
Price change (6M)
-9.8%
Price change (YTD)
-55.6%
Price change (1Y)
-57.7%
Trailing year
Price change (5Y)
-95.2%
52-week high
$0.02
52-week low
$0.00
Change from 52-week high
-75.0%
Change from 52-week low
+34.1%
Annualized volatility
340.2%
Annualized volatility (3M)
—
Beta
-1.4
RSI (14D)
47.6
Price vs SMA 50
-16.6%
Price vs SMA 200
-46.3%
Avg volume (3M)
304,462
Relative volume
3.0
Average dollar volume
$2,086

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
17.53M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-327.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
−$62,365
Operating profit (TTM)
−$106,831
Net income (TTM)
−$263,756
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.02

Growth

11 metrics
Revenue growth YoY
-99.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
−$213,447
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.0%
Year over year
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-100.5%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
-2.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$116,522
Total assets
$262,340
Total debt
$287,471

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$41,547
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1313938 Visit website Investor relations